Kimberly-Clark Gains 1.91% as Analysts Raise Targets Amid Strategic Moves Despite 253rd Trading Volume Rank

On August 4, 2025, Kimberly-Clark (KMB) rose 1.91% with a trading volume of $0.43 billion, a 39.74% decline from the previous day, ranking 253rd in market activity. Goldman Sachs analyst Bonnie Herzog raised the stock’s price target to $145 from $140, maintaining a positive stance on its long-term potential. Piper Sandler initiated coverage with an “Overweight” rating and a $144 target, citing the company’s strategic positioning for sustained growth in diversified product offerings.

The firm reported second-quarter results marked by a 3.9% rise in organic sales driven by its strongest volume growth in five years. Despite a 1.6% decline in net sales, attributed to divestitures and exits from non-core businesses, adjusted earnings exceeded estimates. Management raised its 2025 outlook, projecting low-to-mid single-digit annual profit growth. A $1.26 per share dividend was declared, payable on October 2, reflecting continued shareholder returns.

Strategic moves included the $3.4 billion sale of a majority stake in its international tissue business to Suzano, part of a broader initiative to streamline operations and invest $2 billion in U.S. manufacturing expansion. These actions aim to enhance profitability and accelerate innovation, such as advanced diaper designs. Analysts noted the company’s ability to balance cost pressures from tariffs with resilient demand across product tiers, supported by its broad pricing strategy.

The strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day delivered a 166.71% return from 2022 to the present, outperforming the benchmark return of 29.18% by 137.53%. This underscores the role of liquidity concentration in short-term stock performance, particularly in volatile markets.